Will Patients Bear the Burden for Developing Their Own Treatments?
Soon, you won't only be responsible for managing your disease -- you may also be expected to help find your own cure.… More »
David A. Shaywitz is co-founder of the Harvard PASTEUR program, a research initiative at Harvard Medical School; founding advisor of Sage Bionetworks; and an adjunct scholar at the American Enterprise Institute. More
Soon, you won't only be responsible for managing your disease -- you may also be expected to help find your own cure.… More »
Successfully translating scientific discoveries requires a primal sense of urgency, which some disease foundations seem to have, and many big pharmas appear to need.… More »
The entrepreneur and process methods -- two ways of dealing with the problems created by a business segregated into extreme phenotypes… More »
In the development of drugs, it's too difficult to change things on the fly, and to rapidly pivot in response to an appreciation of customer need… More »
At large, established companies, doing old things more efficiently becomes more important than doing new things. That's the problem.… More »
The challenge for medicine is not only to utilize patient-focused technologies, but also to recognize the unquantifiable benefit that comes from a reassuring nod, a hand on the shoulder… More »
The kind of design thinking championed by Steve Jobs -- human-centered, iterative, and practical -- can fix more than just our gadgets… More »
Once Fat, Always Fat; Another Close Asteroid
Bloomberg: Sleep at Your Desk (But Not With Your Smartphone)
Swedes Can't Wait for Julian Assange to Arrive
